These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Adjusted value of thromboprophylaxis in hospitalized obese patients: A comparative study of two regimens of enoxaparin: The ITOHENOX study. Miranda S; Le Cam-Duchez V; Benichou J; Donnadieu N; Barbay V; Le Besnerais M; Delmas FX; Cuvelier A; Lévesque H; Benhamou Y; Armengol G Thromb Res; 2017 Jul; 155():1-5. PubMed ID: 28460259 [TBL] [Abstract][Full Text] [Related]
4. Enoxaparin dosing after cesarean delivery in morbidly obese women. Overcash RT; Somers AT; LaCoursiere DY Obstet Gynecol; 2015 Jun; 125(6):1371-1376. PubMed ID: 26000508 [TBL] [Abstract][Full Text] [Related]
5. Comparison of anti-Xa levels in obese and non-obese pediatric patients receiving treatment doses of enoxaparin. Richard AA; Kim S; Moffett BS; Bomgaars L; Mahoney D; Yee DL J Pediatr; 2013 Feb; 162(2):293-6. PubMed ID: 22959138 [TBL] [Abstract][Full Text] [Related]
6. Association of Anti-Factor Xa-Guided Dosing of Enoxaparin With Venous Thromboembolism After Trauma. Karcutskie CA; Dharmaraja A; Patel J; Eidelson SA; Padiadpu AB; Martin AG; Lama G; Lineen EB; Namias N; Schulman CI; Proctor KG JAMA Surg; 2018 Feb; 153(2):144-149. PubMed ID: 29071333 [TBL] [Abstract][Full Text] [Related]
7. Use of Enoxaparin in Obese Adolescents During Bariatric Surgery--a Pilot Study. Mushtaq A; Vaughns JD; Ziesenitz VC; Nadler EP; van den Anker JN Obes Surg; 2015 Oct; 25(10):1869-74. PubMed ID: 25716128 [TBL] [Abstract][Full Text] [Related]
8. Optimal enoxaparin dosing strategies for venous thromboembolism prophylaxis and treatment of high body weight patients. Martin AM; Polistena P; Mahmud A; Bettridge B; Morling A; Chuah H; Yong ASM; Leahy MF Thromb Res; 2021 Nov; 207():116-122. PubMed ID: 34619448 [TBL] [Abstract][Full Text] [Related]
9. Enoxaparin Thromboprophylaxis Dosing and Anti-Factor Xa Levels in Low-Weight Patients. Yam L; Bahjri K; Geslani V; Cotton A; Hong L Pharmacotherapy; 2019 Jul; 39(7):749-755. PubMed ID: 31112313 [TBL] [Abstract][Full Text] [Related]
10. Prophylactic Enoxaparin Adjusted by Anti-Factor Xa Peak Levels Compared with Recommended Thromboprophylaxis and Rates of Clinically Evident Venous Thromboembolism in Surgical Oncology Patients. Kramme K; Sarraf P; Munene G J Am Coll Surg; 2020 Mar; 230(3):314-321. PubMed ID: 31843692 [TBL] [Abstract][Full Text] [Related]
13. [Anti-factor Xa activity of enoxaparin for thromboprophylaxis in nonsurgical patients is dependent on body mass]. Jiménez D; Díaz G; Iglesias A; César J; García-Avello A; Martí D; Escobar C; Vidal R; Sueiro A Arch Bronconeumol; 2008 Dec; 44(12):660-3. PubMed ID: 19091234 [TBL] [Abstract][Full Text] [Related]
14. Multicenter study evaluating target attainment of anti-Factor Xa levels using various enoxaparin prophylactic dosing practices in adult trauma patients. Chanas T; Gibson G; Langenstroer E; Herrmann DJ; Carver TW; Alexander K; Chui SHJ; Rein L; Ha M; Maynard KM; Bamberg K; O'Keefe M; O'Brien M; Gonzalez MC; Hobbs B; Pajoumand M; Peppard WJ Pharmacotherapy; 2024 Mar; 44(3):258-267. PubMed ID: 38148134 [TBL] [Abstract][Full Text] [Related]
15. Higher doses of low-molecular-weight heparin (enoxaparin) are needed to achieve target anti-Xa concentrations in critically ill children*. Schloemer NJ; Abu-Sultaneh S; Hanson SJ; Yan K; Hoffmann RG; Punzalan RC; Havens PL Pediatr Crit Care Med; 2014 Sep; 15(7):e294-9. PubMed ID: 24901803 [TBL] [Abstract][Full Text] [Related]
16. A Weight- and Anti-Xa-Guided Enoxaparin Dosing Protocol for venous thromboembolism Prophylaxis in intensive care unit Trauma Patients. Bigos R; Solomon E; Dorfman JD; Ha M J Surg Res; 2021 Sep; 265():122-130. PubMed ID: 33930618 [TBL] [Abstract][Full Text] [Related]
17. Population Pharmacokinetics of Enoxaparin in Pediatric Patients. Moffett BS; Lee-Kim Y; Galati M; Mahoney D; Shah MD; Teruya J; Yee D Ann Pharmacother; 2018 Feb; 52(2):140-146. PubMed ID: 28962537 [TBL] [Abstract][Full Text] [Related]
18. An Evaluation of the Appropriateness of Initial Enoxaparin Dosing Among Pediatric Patients. Altuwayjiri A; AlDarwish A; Alshuraim R Cureus; 2023 Nov; 15(11):e48830. PubMed ID: 38106767 [TBL] [Abstract][Full Text] [Related]
19. Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patients. Rondina MT; Wheeler M; Rodgers GM; Draper L; Pendleton RC Thromb Res; 2010 Mar; 125(3):220-3. PubMed ID: 19272635 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of Body Mass Index-Based Prophylactic Enoxaparin Dosing in Bariatric Surgery Patients. Chang CK; Higgins RM; Rein L; Peppard WJ; Herrmann DJ; Kindel T J Surg Res; 2023 Jul; 287():168-175. PubMed ID: 36933548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]